000 | 01017 a2200313 4500 | ||
---|---|---|---|
005 | 20250517192218.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a2055-2238 | ||
024 | 7 |
_a10.1002/osp4.133 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEngelbrechtsen, L | |
245 | 0 | 0 |
_aTreatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB. _h[electronic resource] |
260 |
_bObesity science & practice _c12 2017 |
||
300 |
_a425-433 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aLundgren, J | |
700 | 1 | _aWewer Albrechtsen, N J | |
700 | 1 | _aMahendran, Y | |
700 | 1 | _aIepsen, E W | |
700 | 1 | _aFinocchietto, P | |
700 | 1 | _aJonsson, A E | |
700 | 1 | _aMadsbad, S | |
700 | 1 | _aHolst, J J | |
700 | 1 | _aVestergaard, H | |
700 | 1 | _aHansen, T | |
700 | 1 | _aTorekov, S S | |
773 | 0 |
_tObesity science & practice _gvol. 3 _gno. 4 _gp. 425-433 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/osp4.133 _zAvailable from publisher's website |
999 |
_c27907861 _d27907861 |